Impact of concomitant medication on clinical outcomes in patients with advanced non‐small cell lung cancer treated with immune checkpoint inhibitors: A retrospective study

BACKGROUND: It has recently been suggested that concomitant medication may affect the clinical outcome of patients treated with immune checkpoint inhibitors (ICIs). However, only a few studies on the impact of concomitant medication on immune‐related adverse events (irAEs) have previously been repor...

Descripción completa

Detalles Bibliográficos
Autores principales: Miura, Kaho, Sano, Yoshiyuki, Niho, Seiji, Kawasumi, Kenji, Mochizuki, Nobuo, Yoh, Kiyotaka, Matsumoto, Shingo, Zenke, Yoshitaka, Ikeda, Takaya, Nosaki, Kaname, Kirita, Keisuke, Udagawa, Hibiki, Goto, Koichi, Kawasaki, Toshikatsu, Hanada, Kazuhiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8258365/
https://www.ncbi.nlm.nih.gov/pubmed/33990133
http://dx.doi.org/10.1111/1759-7714.14001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8258365/
https://www.ncbi.nlm.nih.gov/pubmed/33990133
http://dx.doi.org/10.1111/1759-7714.14001

Ejemplares similares